InvestorsHub Logo
Followers 5
Posts 442
Boards Moderated 0
Alias Born 02/12/2008

Re: None

Wednesday, 05/06/2009 11:12:02 AM

Wednesday, May 06, 2009 11:12:02 AM

Post# of 92948
Unlike his usual hype, golbyar from the Yahoo board actually posted something for deep thought:

C/P

As we approach the final days of sideways trading, I must share a few thoughts regarding the stem cell sector....... have you seen what has been accomplished at Wake Forest University's Institute for Regenerative Medicine? Yes or No? Let me when you have located the website and looked at all the accomplishments thus far. Do you know that Robert Lanza, Ceo of Advanced Cell Technology, is adjunct professor at the Wake Forest Univerity School of Medicine and is part of the faculty of Wake Forest University's Institute for Regenerative Medicine? Do you know that the Wake Forest University's Institute for Regenerative Medicine's famous director, Anthony Atala, is a close colleague of Robert Lanza and friend of Advanced Cell Technology.

Do you know that CEO of Biotime, ex CEO of GERN, was the founder of Advanced Cell Technology and readily admits and is actually quite proud to express his most favorable opinion of Advanced Cell Technology. And that Michael West, ex CEO and founder of Gern, current CEO of Biotime, recently said in an article that Advanced Cell Technology's RPE program will gain more attention and be bigger than Gern's spinal cord program.

Do you think Advanced Cell Technology is going at this alone without any external support? Wouldn't you think at least a few of Wake Forest's Institute of Regenerative Medicine's +80 world renowned faculty members might want to their colleague, Robert Lanza, succeed with commercializing stem cell therapies?

How about our association with the Cha Empire? Oh, you thought Cha Biotech was just some run of the mill little organization? Think again, ACTC is now affiliated with the Cha empire by association with Cha Biotech through the JV. "Cha Health Systems, a South Korea-based global corporation whose holdings include Pochon Cha University and its College of Medicine, nine clinics and hospitals in South Korea and the U.S., two research institutes, four Los Angeles-based healthcare management companies, and four medical venture companies," one being our Cha Biotech. Do you think this a strong partner? Yes or No? and Why?

And this is just the beginning. We haven't even announed our first clinical trial, yet we have these affiliations that you'd think only well established corporations could achieve. We don't even have our first product out the door, yet there is high demand for our patents and technology evidenced by our licensing left and right.


Wake Forest site:

http://www.wfirm.org/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.